Visual evoked potentials (VEPs) are a type of electrophysiological testing used by neurologists to diagnose and monitor several neurological diseases and conditions. This test measures the electrical activity of the visual system when presented with a visual stimulus. Visual evoked potentials measure the time it takes for the neural response to a visual stimulus to reach cortical regions of the brain. It uses a machine that displays a series of patterns of lights onto a screen which the patient then looks at. The amount of visual stimulus and the intensity of the stimulus can be altered during the test, which helps to create a range of responses. One of the primary reasons why VEPs are conducted is to monitor brain activity and to diagnose certain neurological disorders. They can help detect problems caused by damage to the nervous system and can be used to monitor the progression of a disease. This type of testing is beneficial to those who suffer from optic neuritis or multiple sclerosis. VEPs also aid in the diagnosis of spinocerebellar ataxia, a disorder characterized by an impaired ability to coordinate motion. VEPs are also used in research studies to investigate how certain stimuli affect the brain. By studying the time it takes for a response from the visual cortex to occur, researchers can gain greater insight into the visual system of humans and animals. Scientists can use this information to help diagnose and treat certain eye diseases, such as glaucoma. In addition to diagnosing and researching disorders, VEPs are also used to monitor changes in vision over time. For example, this type of testing can be used to monitor changes in vision acuity, contrast sensitivity, and color perception. They are also beneficial when used to monitor the effects of treatment on diseases and conditions of the visual system. VEPs play an important role in diagnosing and monitoring several neurological disorders and other conditions of the visual system.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States